Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Community Health Systems, Inc. (CYH) operates as a major healthcare provider across the United States, focusing on the ownership, leasing, and management of general acute care hospitals. The organization offers a comprehensive array of medical services, including emergency care, general and specialized surgical procedures, critical care, internal medicine, obstetrics, and various diagnostic capabilities. Additionally, they provide psychiatric services, rehabilitation programs, skilled nursing, and in-home care.
How they make money
Community Health Systems, Inc. generates revenue primarily by providing healthcare services through its network of affiliated hospitals and outpatient facilities. The company receives payments for these services from various sources, including government programs like Medicare and Medicaid, as well as private managed care organizations and other third-party payors.
Products & services
The company provides a range of healthcare services including general acute care, emergency services, surgical procedures, diagnostic imaging, and outpatient care through its network of hospitals and affiliated facilities.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
The company is significantly dependent on government reimbursement programs, specifically Medicare and Medicaid, which represent a substantial portion of its net operating revenues.
Suppliers, materials & equipment
Medical supply and pharmaceutical distributors — The company relies on various third-party vendors for medical supplies, pharmaceuticals, and equipment; specific supplier names are not disclosed.Source
Strengths
Significant scale and standardized operating systemsSource
Diverse market presence across multiple statesSource
Risks
Dependence on government reimbursement programsSource
Changes in healthcare regulations and payment modelsSource
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-06-30.
Quarterly EPS fell 75.6% versus the same quarter last year.
Review net income and weighted-average shares together. Per-share earnings can change because of operating performance, nonrecurring items or the share denominator.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
25
Poor
PoorElite
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
41
Weak
Financial Strength
40
Business Quality / Moat
43
Management
25
Growth Quality
76
Risk / Durability
20
Weak Company · Expensive Stock
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
20
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
28/100
Building Historical Record
Model Score 28/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
What we like
•Recent buyback activity is present
What to watch
•Elevated debt risk
•Valuation is a weaker part of the current profile
•Revenue fundamentals are weak
Company-specific research
Questions worth answering for CYH
Research inputs 100% complete
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•Can CYH maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•Is CYH's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
•Is CYH's debt load manageable relative to cash generation, interest costs and upcoming maturities?
•What specifically needs to improve for CYH to reach sustainable profitability?
•What future growth or profitability would be needed to justify CYH's current valuation?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for CYH
Detected from reported data — verify before acting.
Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Elevated debt risk
Negative shareholder equity • Interest coverage is below 2x • Cash covers less than 20% of total debt
Community Sentiment
0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)
No personal call yet on CYH.
Potential upside factors
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Significant scale and standardized operating systems.
+Diverse market presence across multiple states.
+Positive free cash flow may provide capacity to invest in growth.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Wall Street Score
Weak25/ 100
Weak (0–50)Fair (51–71)Strong (72+)
Debt
Fair
50
Debt Cost7.5%
Debt Reduction YoY4.3%
Debt / Equity-8.31x
Tap for breakdown →
Revenue
Weak
40
Revenue YoY79.5%
Revenue CAGR-0.0%
Net Margin-1.3%
Tap for breakdown →
Asset
Fair
55
Asset Growth YoY-6.0%
Liquidation/Share-$8.62
Net Assets/MCap4.89x
Tap for breakdown →
Capital
Poor
6
Earnings Yield-74.4%
Buyback Yield0.9%
Debt Cost7.5%
Tap for breakdown →
Management
Poor
25
ROIC-106.8%
ROE21.6%
ROA-2.5%
Tap for breakdown →
Moat
Weak
43
EPS Growth42.3%
FCF/Share Growth16.6%
Rev/Share Growth-3.1%
Tap for breakdown →
Valuation
Poor
0
Intrinsic Value—
Value Reference—
MOS—
Tap for breakdown →
Buffett
Poor
39
Revenue40
Moat43
Valuation0
Tap for breakdown →
MOS
Poor
0
MOS %—
Value Reference—
Deep Discount Reference—
Tap for breakdown →
Financial
Poor
21
Interest Coverage-11.4x
ROIC-106.8%
FCF Yield51.6%
Tap for breakdown →
Master
Poor
18
Financial21
Valuation0
Debt50
Tap for breakdown →
Resilience
Poor
31
Survival Years0.0 yrs
Current Ratio1.46x
FCF Margin1.7%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
6 historical score records available
Previous Score
25
Sep 17, 2026
Change
Unchanged
Current Score
25
Oct 1, 2026
Category Changes
Revenue0
Debt0
Assets0
Capital0
Management0
Moat0
Valuation0
Buffett0
CYH score was unchanged.
Projected Score
Projected Score
17
Projected Change
-7.8 points
Preliminary comparable-period financial changes suggest decline of approximately 7.8 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailable
Current Price
$2.65
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Value Reference: —
Deep Discount Reference: —
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Monetary values in USD. Share counts in raw units.
Income StatementBalance SheetCash Flow
AnnualQuarterlyTTM + Annual
All rows
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
Line Item
TTM
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
$22.41B
$12.48B
$12.63B
$12.49B
····
····
····
····
····
····
····
Cost of Revenue
$9.40B
$11.40B
$7.36B
$7.41B
····
····
····
····
····
····
····
Gross Profit
$13.02B
$1.08B
$5.27B
$5.08B
····
····
····
····
····
····
····
Research & Development
$0.00
$0.00
$0.00
$80.0M
····
····
····
····
····
····
····
SG&A Expenses
$11.79B
$0.00
$299.0M
$319.0M
····
····
····
····
····
····
····
Operating Expenses
$21.70B
$11.00B
$4.73B
$4.13B
····
····
····
····
····
····
····
EBITDA
$4.91B
$2.02B
$1.25B
$1.29B
····
····
····
····
····
····
····
Operating Income
-$8.68B
-$9.91B
$542.0M
$957.0M
····
····
····
····
····
····
····
Interest Expense
$856.0M
$870.0M
$863.0M
$832.0M
····
····
····
····
····
····
····
Income Before Tax
-$481.0M
$724.0M
-$283.0M
$207.0M
····
····
····
····
····
····
····
Income Tax Expense
$66.0M
$48.0M
$79.0M
$191.0M
····
····
····
····
····
····
····
Net Income
-$300.0M
$509.0M
-$516.0M
-$133.0M
····
····
····
····
····
····
····
Basic EPS
$-2.26
$3.80
$-3.90
$-1.02
····
····
····
····
····
····
····
Basic Shares
135M
134M
132M
130M
····
····
····
····
····
····
····
Diluted Shares
136M
135M
132M
130M
····
····
····
····
····
····
····
Upgrade to Premium for up to 10 annual periods, where available.
Estimated earnings date:A future estimated earnings date is not currently available.
Jun 30, 2026Q2FY2026
Revenue
$4.06B
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$0.51
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-11.2%
Cash Change
-67.3%
Margin Change
-7.3 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
Debt reduced
What Weakened
Margins contracted
Cash position declined
Potential Score Impact
Positive indicators included revenue growth, debt levels. Pressure indicators included EPS growth, cash levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 29.7%. EPS declined 75.6%. Cash declined 67.3%. Total debt declined 11.2%. Net income margin declined by 7.3 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.
Dividend HistoryShare
Dividend History
Log in to view dividend history.
Log In
Predictions & Historical PerformanceShare
Conservative Projected Values
3 Years
$———.——
Premium
5 Years
$———.——
Premium
10 Years
$———.——
Premium
Conservative Projection Rate
——%
Premium
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.